HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)
2026-03-18 02:12:07 ET
Shares of HealthEquity ( HQY ) have been a poor performer over the past year, losing about 20% of their value. While the company has reported solid financial results, shares have been weighed down by its valuation. Plus, the failure to extend Obamacare subsidies has raised concern over a potential decline in insurance rates, which could reduce HSA account growth, a headwind for HQY. I last covered shares of HealthEquity in June , when I rated the stock a "hold," given a full valuation but clear tailwinds from interest rates and account growth. That outlook proved too optimistic, with shares down 29% since then, making a sell the appropriate recommendation. With updated financials, now is a good time to revisit HQY to see if shares are cheap enough to buy....
Read the full article on Seeking Alpha
For further details see:
HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)NASDAQ: HQY
HQY Trading
-0.03% G/L:
$81.69 Last:
237,022 Volume:
$82.43 Open:



